Status: Recruiting
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
A randomized controlled trial was conducted to evaluate the efficacy and safety of Yangxinshi tablets in improving the condition of patients with coronary heart disease complicated by cardiac dysfunction.
Participants needed: 2,708
Trial details
Phase: Phase 4Age: 40-80Biological sex: AllType: InterventionalSponsor: SPH Qingdao Growful Pharmacetical Co.,LtdUpdated: Nov 25, 2025Locations: 96
Eligibility criteria
For inpatients diagnosed with coronary heart disease (including acute coronary s... [+5]
Patients with STEMI within 3 days; [+11]